PMC:7556165 / 4276-4448 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T26","span":{"begin":14,"end":24},"obj":"Species"},{"id":"T27","span":{"begin":14,"end":18},"obj":"Species"}],"attributes":[{"id":"A26","pred":"ncbi_taxonomy_id","subj":"T26","obj":"NCBItxid:2697049"},{"id":"A27","pred":"ncbi_taxonomy_id","subj":"T27","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ilability for SARS-CoV-2 binding, have been identified as a novel goal of pharmaceutical research.\nThe purpose of the present review is to summarize the available knowledge"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"147","span":{"begin":14,"end":24},"obj":"Species"}],"attributes":[{"id":"A147","pred":"pubann:denotes","subj":"147","obj":"Tax:2697049"}],"text":"ilability for SARS-CoV-2 binding, have been identified as a novel goal of pharmaceutical research.\nThe purpose of the present review is to summarize the available knowledge"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T35","span":{"begin":14,"end":24},"obj":"Disease"},{"id":"T36","span":{"begin":14,"end":18},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ilability for SARS-CoV-2 binding, have been identified as a novel goal of pharmaceutical research.\nThe purpose of the present review is to summarize the available knowledge"}

{"project":"LitCovid-PubTator","denotations":[{"id":"147","span":{"begin":14,"end":24},"obj":"Species"}],"attributes":[{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ilability for SARS-CoV-2 binding, have been identified as a novel goal of pharmaceutical research.\nThe purpose of the present review is to summarize the available knowledge"}